Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Molecular Cloning and Functional Characterization of Mouse α3(IV)NC1

View through CrossRef
Non-collagenous α3 chain of type IV collagen or α3(IV)NC1, a 28 kDa C-terminal domain of collagen type IV is a specific inhibitor of endothelial cell translation and angiogenesis. In the present study we have cloned and expressed mouse α3(IV)NC1 in baculovirus system. The recombinant protein was expressed in soluble form and tested for several of its biological functions. We identified that this recombinant mouse α3(IV)NC1 specifically inhibited proliferation, translation and tube formation of endothelial cells. Also, we show that α3(IV)NC1 treatment results in apoptosis specifically in proliferating endothelial cells. In addition we report for the first time that mouse α3(IV)NC1 inhibits migration and p38 MAPK phosphorylation in addition to inhibition of FAK/Akt/mTOR/4E-BP1 signaling. In mice α3(IV)NC1 treatment reduced tumor growth and CD-31 positive endothelial vasculature in tumors. Collectively, our data demonstrate the expression of biologically active form of mouse α3(IV)NC1 in Sf-9 cells and provide important mechanistic insights on α3(IV)NC1 antiangiogenic actions in endothelial cells.
Title: Molecular Cloning and Functional Characterization of Mouse α3(IV)NC1
Description:
Non-collagenous α3 chain of type IV collagen or α3(IV)NC1, a 28 kDa C-terminal domain of collagen type IV is a specific inhibitor of endothelial cell translation and angiogenesis.
In the present study we have cloned and expressed mouse α3(IV)NC1 in baculovirus system.
The recombinant protein was expressed in soluble form and tested for several of its biological functions.
We identified that this recombinant mouse α3(IV)NC1 specifically inhibited proliferation, translation and tube formation of endothelial cells.
Also, we show that α3(IV)NC1 treatment results in apoptosis specifically in proliferating endothelial cells.
In addition we report for the first time that mouse α3(IV)NC1 inhibits migration and p38 MAPK phosphorylation in addition to inhibition of FAK/Akt/mTOR/4E-BP1 signaling.
In mice α3(IV)NC1 treatment reduced tumor growth and CD-31 positive endothelial vasculature in tumors.
Collectively, our data demonstrate the expression of biologically active form of mouse α3(IV)NC1 in Sf-9 cells and provide important mechanistic insights on α3(IV)NC1 antiangiogenic actions in endothelial cells.

Related Results

From Discrete Molecular Cages to a Network of Cages Exhibiting Enhanced CO2 Adsorption Capacity
From Discrete Molecular Cages to a Network of Cages Exhibiting Enhanced CO2 Adsorption Capacity
AbstractWe have adopted the concept of “cage to frameworks” to successfully produce a Na–N connected coordination networked cage Na‐NC1 by using a [3+6] porous imine‐linked organic...
Gregory pence onhuman cloning: An ethical evaluation
Gregory pence onhuman cloning: An ethical evaluation
Human cloning is one of the new reproductive technologies. It is among the most controversial and hotly debated topic in bioethics. The central point of controversy has been, is it...
Cloning and Expression Vectors
Cloning and Expression Vectors
Cloning and expression vectors are essential tools in molecular biology that enable researchers to manipulate and study genes and proteins. Cloning vectors are DNA molecules that c...
Abstract 5051: RenMab Mouse: A leading platform for fully human antibody generation
Abstract 5051: RenMab Mouse: A leading platform for fully human antibody generation
Abstract With the development of immune-oncology, therapeutic antibodies have been proven to be extraordinarily effective for cancer treatment. Conventional human an...
A Novel Enzyme-Free Approach for Precursor microRNA Cloning and Expression
A Novel Enzyme-Free Approach for Precursor microRNA Cloning and Expression
Abstract Background: Traditional cloning methods heavily depend on enzymatic digestion for generating sticky ends in DNA inserts, presenting challenges in efficiency and co...

Back to Top